Deutsch English Français

Contact

EP0983765

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0983765

EP0983765 - PREVENTIVES OR REMEDIES FOR DISEASES IN ASSOCIATION WITH VASCULAR FUNCTIONAL ANOMALY RELATING TO INSULIN RESISTANCE [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 14.09.2007 Database last updated on 19.07.2024
Most recent event Tooltip	08.01.2010	Lapse of the patent in a contracting state New state(s): CY, LU	published on 10.02.2010 [2010/06]
Applicant(s)	For all designated states Daiichi Asubio Pharma Co., Ltd. 9-11, Akasaka 2-chome, Minato-ku Tokyo 1078541 / JP
	[N/P]
Former [2005/52]	For all designated states Daiichi Asubio Pharma Co., Ltd. 9-11, Akasaka 2-chome, Minato-ku Tokyo 107-8541 / JP
Former [2003/22]	For all designated states Daiichi Suntory Pharma Co., Ltd. 5-7-2, Kojimachi, Chiyoda-ku Tokyo / JP
Former [2000/10]	For all designated states SUNTORY LIMITED 1-40, Dojimahama 2-chome, Kita-ku Osaka-shi, Osaka 530-8203 / JP
Inventor(s)	01 / KASHIWAGI, Atsunori 832-15, Oishihigashicho Otsu-shi Shiga 520-2264 / JP
	02 / SHINOZAKI, Kazuya 602, Gurandoru Ichiriyama 1-4-1, Ichiriyama Otsu-shi Shiga 520-2153 / JP
	03 / NISHIO, Yoshihiko 5-25-504, Nishinosho Otsu-shi Shiga 520-0818 / JP
	04 / OKAMURA, Tomio 6-2-14, Aoyama Otsu-shi Shiga 520-2101 / JP
	05 / TODA, Noboru 7-11-23, Yamamotocho Minami Yao-shi Osaka 581-0013 / JP
	06 / KIKKAWA, Ryuichi 1-11-15, Uenosaka Toyonaka-shi Osaka 560-0012 / JP
	[2000/10]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE
	[N/P]
Former [2000/10]	HOFFMANN - EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE
Application number, filing date	99906501.4	26.02.1999
	[2000/10]
	WO1999JP00917
Priority number, date	JP19980047720	27.02.1998 Original published format: JP 4772098
	[2000/10]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9943325
	Date:	02.09.1999
	Language:	EN
	[1999/35]
	Type:	A1 Application with search report
	No.:	EP0983765
	Date:	08.03.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.09.1999 takes the place of the publication of the European patent application.
	[2000/10]
	Type:	B1 Patent specification
	No.:	EP0983765
	Date:	27.09.2006
	Language:	EN
	[2006/39]
Search report(s)	International search report - published on:	JP	02.09.1999
	(Supplementary) European search report - dispatched on:	EP	21.02.2001
Classification	IPC:	A61K31/519, A61P9/10, A61P9/00, A61P3/00	[2006/11]
	CPC:	A61K31/505 (EP,US); A61K31/519 (EP,US); A61P3/00 (EP); A61P3/06 (EP); A61P3/08 (EP); A61P3/14 (EP); (+) A61P41/00 (EP); A61P43/00 (EP); A61P9/00 (EP); A61P9/08 (EP); A61P9/10 (EP); A61P9/12 (EP) (-)
	Former IPC [2006/10]	A61K31/525, A61P9/10, A61P9/00, A61P3/00
	Former IPC [2001/14]	A61K31/525, // C07D475:04
	Former IPC [2000/10]	A61K31/505, // C07D475:04
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/10]
Title	German:	VORBEUGUNG UND BEHANDLUNG VON KRANKHEITEN IN ZUSAMMENHANG ZU VASKULAREN FUNKTIONELLEN STOERUNGEN UN VERBINDUNG MIT INSULINRESISTENZ	[2000/10]
	English:	PREVENTIVES OR REMEDIES FOR DISEASES IN ASSOCIATION WITH VASCULAR FUNCTIONAL ANOMALY RELATING TO INSULIN RESISTANCE	[2000/10]
	French:	REMEDES PREVENTIFS OU THERAPEUTIQUES CONTRE LES MALADIES ASSOCIEES A UNE ANOMALIE FONCTIONNELLE VASCULAIRE EN RELATION AVEC LA RESISTANCE A L'INSULINE	[2000/10]
Entry into regional phase	27.10.1999	Translation filed
	27.10.1999	National basic fee paid
	27.10.1999	Search fee paid
	27.10.1999	Designation fee(s) paid
	25.02.2000	Examination fee paid
Examination procedure	25.02.2000	Examination requested [2000/17]
	26.03.2004	Despatch of a communication from the examining division (Time limit: M06)
	27.09.2004	Reply to a communication from the examining division
	26.04.2005	Despatch of a communication from the examining division (Time limit: M06)
	03.11.2005	Reply to a communication from the examining division
	20.02.2006	Communication of intention to grant the patent
	16.06.2006	Fee for grant paid
	16.06.2006	Fee for publishing/printing paid
Opposition(s)	28.06.2007	No opposition filed within time limit [2007/42]
Fees paid	Renewal fee
	16.02.2001	Renewal fee patent year 03
	26.02.2002	Renewal fee patent year 04
	24.02.2003	Renewal fee patent year 05
	23.02.2004	Renewal fee patent year 06
	21.02.2005	Renewal fee patent year 07
	22.02.2006	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	27.09.2006
	LU	26.02.2007
	MC	28.02.2007
	[2010/06]
Former [2008/17]	MC	28.02.2007
Documents cited:	Search	[Y]JPH0656669 ;
		[X] - WALTER R. ET AL, "Inhalation of the nitric oxide synthase cofactor tetrahydrobiopterin in healthy volunteers.", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (1997) 156/6 (2006-2010)., XP000973868 [X] 1,2 * abstract * * page 2009 *
		[Y] - PATENT ABSTRACTS OF JAPAN, (19940603), vol. 018, no. 291, Database accession no. (C - 1208), & JP06056669 A 19940301 (ASAHI BREWERIES LTD) [Y] 3-11 * abstract *
		[Y] - WEVER, ROBERT M. F. ET AL, "Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase", BIOCHEM. BIOPHYS. RES. COMMUN. ( 1997 ), 237(2), 340-344, XP000891678 [Y] 3-11 * abstract * DOI: http://dx.doi.org/10.1006/bbrc.1997.7069
		[Y] - PRAST ET AL, "Effects of sepiapterin treatment on tetrahydrobiopterin levels and blood pressure in spontaneously hypertensive rats", BIOLOGY OF NITRIC OXIDE,XX,XX, (1992), no. 1, pages 10 - 12, XP000901316 [Y] 3-11 * page 12 *
		[Y] - PINKNEY J H ET AL, "Endothelial dysfunction: cause of the insulin resistance syndrome.", DIABETES, (1997 SEP) 46 SUPPL 2 S9-13., XP000973930 [Y] 3-11 * abstract * * page S12 *
		[Y] - HIGASHI Y ET AL, "Relationship between insulin resistance and endothelium -dependent vascular relaxation in patients with essential hypertension.", HYPERTENSION, (1997 JAN) 29 (1 PT 2) 280-5., XP000973931 [Y] 3-11 * abstract * * page 284 *
	International search	[A]JPS5925323 (HANSUUKURISUTOFU KURUTEIUSU, et al);
		[A]JPS5976086 (WELLCOME FOUND);
		[A]JPS61277618 (SUNTORY LTD);
		[A]JPS63267781 (SUNTORY LTD);
		[A] - SHIMIZU M, ET AL., "NITRIC OXIDA AND HYPOXIA INDUCE UP-REGULATION OF FAS IN HUMAN VASCULAR SMOOTH MUSCLE CELLS", JAPANESE JOURNAL OF PHARMACOLOGY., THE JAPANESE PHARMACOLOGICAL SOCIETY, KYOTO, JP, KYOTO, JP, (19970101), vol. 75, no. SUPPL. 01, ISSN 0021-5198, page 11P, XP002929217
		[A] - GARY H. GIBBONS ET AL, "Molecular Therapies for Vascular Diseases", SCIENCE, (19960503), vol. 272, pages 689 - 693, XP002929218 DOI: http://dx.doi.org/10.1126/science.272.5262.689

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p